You don't need to be signed in to read BMJ Blogs, but you can register here to receive updates about other BMJ products and services via our site.

Obstructive sleep apnea

CPAP fails to improve cardiovascular outcomes in OSA

6 Jan, 17 | by flee

Obstructive sleep apnea (OSA) is associated with increased cardiovascular events in observational studies. Randomized trials have demonstrated continuous positive airway pressure (CPAP) therapy reduces blood pressure, markers of oxidative stress and insulin insensitivity.  Yet, it remains unclear whether treatment with CPAP reduces cardiovascular events.  In the largest study of its kind, 2717 patients aged 45 to 75 years with moderate-to-severe OSA and coronary or cerebrovascular disease were randomized in open-label fashion to receive CPAP treatment or usual care alone. The primary composite end point included cardiovascular death, myocardial infarction, stroke and heart failure with secondary end-points including day-time sleepiness, mood and quality of life indices. At a mean follow-up of 3.7 years, the trial was neutral with no difference in the primary end-point between the CPAP (17.0%) and the usual-care groups (15.4%) (P=0.34), and no difference in the individual components of the primary end-point.  CPAP however significantly improved snoring, daytime sleepiness, mood and health-related quality of life.



Highlighted articles from non-cardiological journals relevant to cardiology.


An international peer review journal that keeps cardiologists up to date with advances in the diagnosis and treatment of cardiovascular disease. Visit site

Creative Comms logo

Latest from Heart

Latest from Heart

Cardiology Masterclasses

Cardiology Masterclasses